Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2011-11-08 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2011年第二次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, and resolutions of the 2011 second extraordinary shareholders' meeting of Beijing Shuanglu Pharmaceutical Co., Ltd. It details the legality of the meeting's call, attendance, agenda, voting procedures, and results. The document is not a report of financial results, audit, or management discussion, but rather a legal opinion on the shareholders' meeting process and outcomes. It includes voting results and confirms the legality and validity of the meeting and resolutions. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting. The document length is 2852 characters, which is relatively short but contains detailed voting results and legal opinion, not just an announcement of a report publication. Therefore, the best classification is DVA with high confidence.
2011-11-08 Chinese
关于召开2011年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice about convening the 2011 second extraordinary general meeting of shareholders for Beijing Shuanglu Pharmaceutical Co., Ltd. It includes details such as meeting time, location, agenda items for shareholder approval, registration procedures, and proxy forms. There are no financial statements or results presented, nor is it a transcript or report of the meeting outcomes. The document is an announcement informing shareholders about the upcoming meeting and the matters to be discussed and voted on. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to request votes for meetings.
2011-10-20 Chinese
公司章程（2011年10月）
Governance Information Classification · 100% confidence The document is a detailed corporate charter or articles of association for Beijing SL Pharmaceutical Co., Ltd. It includes chapters on company general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, and other governance-related rules. The content focuses on the company's internal rules, shareholder rights, board structure, meeting procedures, and management responsibilities. There is no indication of financial statements, audit opinions, earnings data, or investor presentations. The document is not an announcement or a brief summary but a comprehensive governance document. Therefore, it fits the category of Governance Information (CGR).
2011-10-20 Chinese
2011年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2011 Third Quarter Quarterly Report" of Beijing Shuanglu Pharmaceutical Co., Ltd. It contains detailed financial data for the third quarter of 2011, including key accounting data, financial indicators, shareholder information, and explanations of significant changes in financial items. The report explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending September 30, 2011. The length of the document (5251 characters) and the detailed financial content confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2011
2011-10-20 Chinese
第四届董事会第二十三次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting, including approval of a quarterly report, proposals for capital increase, amendments to the company bylaws, and the scheduling of a shareholders meeting. It includes voting results and references to submitting certain matters to a shareholders meeting. The document does not contain the full quarterly report or detailed financial statements but rather announces decisions and approvals made by the board. The document length is short (1949 characters) and it primarily serves as a board meeting resolution announcement. This fits best under Board/Management Information (MANG), which covers announcements of board decisions and management changes or resolutions. It is not an actual financial report (like an Interim Report), nor a report publication announcement, nor a proxy solicitation. Therefore, the correct classification is MANG with high confidence.
2011-10-20 Chinese
2011年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2011 Third Quarter Quarterly Report" of Beijing Shuanglu Pharmaceutical Co., Ltd. It contains detailed financial data including balance sheets, income statements, and explanations of significant changes in financial metrics for the third quarter of 2011. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2011
2011-10-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.